[en] The present invention provides a method for treating or preventing a disorder typified by an immunodificiency (e.g. HIV), wherein the patient is administered a COX-2 inhibitor or derivative or pharmaceutically acceptable salt thereof, preferably diisopropylfluorophasphaate, L-745337, rofecoxi, NS 398, SC 58125, etodolac, meloxicam, celecoxib flusolide or nimesulide, and compositions and products containing the same or use of the same in preparing medicaments and for treatment.
Disciplines :
Immunology & infectious disease
Inventor :
TASKÉN, Kjetil
Moutschen, Michel ; Université de Liège - ULiège > Maladies infectieuses et médecine interne générale
Rahmouni, Souad ; Université de Liège - ULiège > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén.
Aandahl, Einar Martin
AUKRUST, Pål
FRØLAND, Stig, S
JOHANSSON, Christian, Carl
HANSSON, Vidar
KLAVENESS, Jo
Language :
English
Title (54) :
USE OF COX-2 INHIBITORS FOR PREVENTING IMMUNODEFICIENCY
Publication date (43-45) :
31 January 2002
Filing date (22) :
20 July 2001
Patent/publication number (10-11) :
WO/2002/007721
Patent status (13) :
A
Priority number (30) :
017908.5 GB 20.07.2000 and 0109648.6 GB 19.04.2001